The CBD-ilemma

15 March 2023 The CBD-ilemma Author: Multidisciplinary Team at Zerenia Reviewed and Edited By: Guillermo Moreno-Sanz, Ph.D. The approval of epidyolex for the treatment of refractory pediatric epilepsy is providing an increasing body of evidence on the therapeutic potential of cannabidiol (CBD), which had already showed promise to address other clinical conditions such as anxiety, […]

The CBD-ilemma Read More »